Swat­ting away a takeover at­tempt, Zymeworks keeps re­tool­ing staff; Af­ter Cyg­nal-ing her ex­it from Flag­ship, Pearl Huang starts afresh

Zymeworks used a poi­son pill ma­neu­ver a cou­ple weeks ago as the coun­ter­punch to a $773 mil­lion takeover bid by All Blue …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.